2007
DOI: 10.1016/j.nurt.2007.08.004
|View full text |Cite
|
Sign up to set email alerts
|

Statins—Treatment Option for Central Nervous System Autoimmune Disease?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
17
0
1

Year Published

2008
2008
2015
2015

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 21 publications
(18 citation statements)
references
References 77 publications
0
17
0
1
Order By: Relevance
“…The categories protein amino acid prenylation, protein prenylation and protein farnesylation are also linked to cholesterol biosynthesis. The genes with the highest importance scores in this group were farnesyltransferase‐α and the expressed sequence AA409500 related to farnesyltransferase‐β, which are involved in the post‐translational prenylation and farnesylation of several proteins, including the small GTP‐binding proteins RAB and RAS [43]. Both showed a mild decreasing expression pattern, reaching a –1.16 and –1.40‐fold down‐regulation at 196 dpi, respectively (EDGE, q < 0.001, and q = 0.002).…”
Section: Resultsmentioning
confidence: 99%
“…The categories protein amino acid prenylation, protein prenylation and protein farnesylation are also linked to cholesterol biosynthesis. The genes with the highest importance scores in this group were farnesyltransferase‐α and the expressed sequence AA409500 related to farnesyltransferase‐β, which are involved in the post‐translational prenylation and farnesylation of several proteins, including the small GTP‐binding proteins RAB and RAS [43]. Both showed a mild decreasing expression pattern, reaching a –1.16 and –1.40‐fold down‐regulation at 196 dpi, respectively (EDGE, q < 0.001, and q = 0.002).…”
Section: Resultsmentioning
confidence: 99%
“…Nonetheless, important aspects of the etiopathogenesis of MS, including susceptibility genes, mechanisms of immune cell activation, immunoregulatory circuits, and mechanisms of axonal damage and repair have been elucidated by studying animal models. Moreover, several emerging MS therapies are currently in the preclinical testing phase in EAE or TMEV-IDD models (Weber et al, 2007). However, further improvements in the animal models used to study MS are required so that they may better reflect the pathogenesis and heterogeneity of this disease (Baker and Amor, 2011;Moreno et al, 2012).…”
Section: Unsuccessful Ms Therapiesmentioning
confidence: 99%
“…Because of the controversial discussion about the efficacy of statins, 3-hydroxy-3-methylglutaryl-coenzyme-A reductase (HMG-CoA-reductase) inhibitors (93), as possible treatment of MS, further studies investigating the interaction between demyelinating diseases and cholesterol biosynthesis are required. In particular, studies that address the role of cholesterol biosynthesis on disease progression of MS, with particular emphasis on its potential beneficial effect on remyelination, are required.…”
Section: Introductionmentioning
confidence: 99%